What type of study is this?

This is a Experimental Study study.

September 30, 2025Open Access

Network pharmacology, bioinformatics, molecular docking and experimental verification of the mechanism of HXZTS treatment on osteoarthritis synovium

View Full Paper

Ask AI

Bookmark

Authors

Integration of network pharmacology and molecular docking reveals HXZTS targets inflammation in osteoarthritis, suggesting new therapeutic avenues.

HXZTS treatment reduced inflammatory mediators IL6 and PTGS2 while promoting cartilage repair gene expression MMP1 and MMP3.
Network analysis identified 21 active ingredients and 111 targets associated with HXZTS, highlighting quercetin and β-sitosterol.
Molecular docking demonstrated strong binding affinities of HXZTS compounds with targets including AKT1, TNF, and TP53.
The multifaceted mechanism of HXZTS involves modulation of inflammation, oxidative stress, and metabolic pathways.

Chen et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

September 30, 2025Open Access

View Full Paper

Ask AI

Bookmark

Authors

Integration of network pharmacology and molecular docking reveals HXZTS targets inflammation in osteoarthritis, suggesting new therapeutic avenues.

HXZTS treatment reduced inflammatory mediators IL6 and PTGS2 while promoting cartilage repair gene expression MMP1 and MMP3.
Network analysis identified 21 active ingredients and 111 targets associated with HXZTS, highlighting quercetin and β-sitosterol.
Molecular docking demonstrated strong binding affinities of HXZTS compounds with targets including AKT1, TNF, and TP53.
The multifaceted mechanism of HXZTS involves modulation of inflammation, oxidative stress, and metabolic pathways.

Chen et al. (2025) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark